What are the requirements for submitting a “Sequence Listing” in a patent application?
According to MPEP 2427, patent applications containing nucleotide and/or amino acid sequence disclosures must include a “Sequence Listing” as a separate part of the disclosure. This can be submitted in several ways:
- As an ASCII text file via the USPTO’s electronic filing system
- On read-only optical discs
- As a PDF file via EFS-Web or Patent Center (not recommended)
- On physical sheets of paper (not recommended)
The “Sequence Listing” must be in accordance with the requirements of 37 CFR 1.821-1.825. Additionally, a computer readable form (CRF) of the “Sequence Listing” is required in most cases.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2427 - Form Paragraphs For Applications Subject To Wipo St.25,
Patent Law,
Patent Procedure